Loading...

Purified anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1dot5_Pure_021706
BALB/c mouse splenocytes were stained with purified CD4 (clone GK1.5) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC.
  • GK1dot5_Pure_021706
    BALB/c mouse splenocytes were stained with purified CD4 (clone GK1.5) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100401 50 µg £17
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100402 500 µg £53
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, IP - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  2. Liao X, et al. 2022. Front Immunol. 12:768813. PubMed
  3. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  4. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  5. Yu H, et al. 2020. Front Immunol. 11:1773. PubMed
  6. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  7. Ngwenyama N, et al. 2022. Nat Cardiovasc Res. 1:761. PubMed
  8. Zhang S, et al. 2017. Nature.. 10.1038/nature24283. PubMed
  9. Chami B, et al. 2017. Sci Rep. 7:10181. PubMed
  10. Tsukumo S, et al. 2006. J Immunol. 177:8365. PubMed
  11. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  12. Landuyt AE, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  13. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  14. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  15. Murata A, et al. 2020. Front Immunol. 11:775. PubMed
  16. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  17. Hummel JF, et al. 2020. Mucosal Immunol. 0.720138889. PubMed
  18. Smith CJ, et al. 2018. J Immunol. 200:1580. PubMed
  19. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  20. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  21. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  22. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  23. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  24. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  25. Yang J, et al. 2020. Front Immunol. 10:3048. PubMed
  26. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  27. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  28. Duvvuri M, et al. 2019. Biomater Sci. 7:1863. PubMed
  29. Hashimoto K, et al. 2021. J Dermatol Sci. 102:177. PubMed
  30. Haque M, et al. 2021. Viruses. 13:. PubMed
  31. Mayer JU, et al. 2020. Front Immunol. 11:592325. PubMed
  32. Tian K, et al. 2021. J Immunol Res. 2021:6297332. PubMed
  33. Hirano J, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  34. Draganov D, et al. 2021. NPJ Breast Cancer. 7:22. PubMed
  35. Rossi DC, et al. 2021. J Clin Invest. 131:. PubMed
  36. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  37. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  38. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  39. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  40. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  41. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  42. Xie MM, et al. 2017. Eur J Immunol. 47:1136. PubMed
  43. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  44. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  45. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  46. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  47. Lasrado N, et al. 2021. Microorganisms. 9:. PubMed
  48. Tan L, et al. 2017. Int J Nanomedicine. 12:3095. PubMed
  49. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  50. Wang N, et al. 2021. Mol Ther Oncolytics. 20:71. PubMed
  51. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  52. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  53. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  54. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  55. Sharma M, et al. 2020. Nat Commun. 11:661. PubMed
  56. Skeate JG, et al. 2018. PLoS One. 13:e0191311. PubMed
  57. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  58. Yang SH, et al. 2017. Front Immunol. 8:1192. PubMed
  59. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  60. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  61. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  62. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  63. Ma W, et al. 2017. Sci Rep. . 10.1038/s41598-017-15661-6. PubMed
  64. Overacre-Delgoffe AE, et al. 2017. Cell. 169:1130. PubMed
  65. Elsayed H, et al. 2018. J Virol. 92:e00428. PubMed
  66. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  67. Hu M, et al. 2008. J Immunol. 180:6593. PubMed
  68. Hsiao CC, et al. 2021. Cells. 10:. PubMed
  69. Horiuchi S, et al. 2021. Sci Immunol. :eabm3131. PubMed
  70. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  71. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  72. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  73. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  74. Kinosada H, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006120. PubMed
  75. Pierini A, et al. 2017. JCI Insight. 2. PubMed
  76. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  77. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  78. Liu M, et al. 2018. Diabetologia. 61:2333. PubMed
  79. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  80. Majer O, et al. 2019. Nature. 575:366. PubMed
  81. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  82. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  83. Zelazowska MA, et al. 2020. Life Sci Alliance. :3. PubMed
  84. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  85. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  86. Yates K, et al. 2018. Proc Natl Acad Sci U S A. 115:2162. PubMed
  87. Zhang H, et al. 2017. J Immunol. 198:2133. PubMed
  88. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  89. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  90. Zander R, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.10.077. PubMed
  91. Ikezoe T, et al. 2021. Biomolecules. 11:. PubMed
  92. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  93. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  94. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  95. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  96. Rosenbaum M, et al. 2019. Nat Commun. 2.05. PubMed
  97. Meyers JL, et al. 2018. PLoS One. 13:e0207007. PubMed
  98. Floudas A, et al. 2017. J Immunol. 199:707. PubMed
  99. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  100. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  101. Tsai MS, et al. 2021. Int J Mol Sci. 22:. PubMed
  102. Pradhan P, et al. 2017. JCI Insight. 2. PubMed
  103. Song K, et al. 2017. Oncotarget. 8:38554. PubMed
  104. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  105. Duncan CG, et al. 2018. G3 (Bethesda). 0.892361111. PubMed
  106. Wilhelmson AS, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1519. PubMed
  107. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  108. Stefanski HE, et al. 2018. PLoS One. 13:e0198871. PubMed
  109. Liu J, et al. 2022. Stem Cell Res Ther. 13:247. PubMed
  110. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  111. Zhang Z, et al. 2020. Front Immunol. 1.844444444. PubMed
  112. Rosenberg J, et al. 2020. Cell Systems. 10(5):433-444. PubMed
  113. Scutts SR, et al. 2018. Cell Rep. 25:1953. PubMed
  114. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  115. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  116. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  117. Luu M, et al. 2019. Nat Commun. 10:760. PubMed
  118. Di Dalmazi G, et al. 2019. J Immunol. 202:1350. PubMed
  119. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  120. Fujimura N, et al. 2016. J Vasc Surg. 64: 46-54. PubMed
  121. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  122. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  123. Zhang N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  124. Whittle JR, et al. 2020. Clin Cancer Res. 26:4120. PubMed
  125. Liu H, et al. 2022. Animal Model Exp Med. 5:72. PubMed
  126. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  127. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  128. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  129. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  130. Krämer TJ, et al. 2019. J Neuroinflammation. 16:163. PubMed
  131. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  132. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
RRID
AB_312686 (BioLegend Cat. No. 100401)
AB_312686 (BioLegend Cat. No. 100402)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC,IHC-F,ICC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
PE/Cyanine7 anti-mouse CD4 GK1.5 FC
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F,ICC
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F,ICC
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,ICC,SB
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC,IHC-F,ICC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account